PMC:7105881 / 34769-35096 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1099","span":{"begin":116,"end":124},"obj":"Species"},{"id":"1100","span":{"begin":139,"end":144},"obj":"Species"},{"id":"1101","span":{"begin":263,"end":271},"obj":"Species"}],"attributes":[{"id":"A1099","pred":"tao:has_database_id","subj":"1099","obj":"Tax:694009"},{"id":"A1100","pred":"tao:has_database_id","subj":"1100","obj":"Tax:9606"},{"id":"A1101","pred":"tao:has_database_id","subj":"1101","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"llenge (Du et al., 2009b). Particularly, RBDs from the S proteins of Tor2, GD03, and SZ3, representative strains of SARS-CoV isolated from human 2002–2003, 2003–2004, and palm civet strains, can induce high-titer cross-neutralizing antibodies against pseudotyped SARS-CoV expressing respective S proteins (He et al., 2006c). Di"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T196","span":{"begin":57,"end":65},"obj":"Body_part"},{"id":"T197","span":{"begin":171,"end":175},"obj":"Body_part"},{"id":"T198","span":{"begin":296,"end":304},"obj":"Body_part"}],"attributes":[{"id":"A196","pred":"fma_id","subj":"T196","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A197","pred":"fma_id","subj":"T197","obj":"http://purl.org/sig/ont/fma/fma24920"},{"id":"A198","pred":"fma_id","subj":"T198","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"llenge (Du et al., 2009b). Particularly, RBDs from the S proteins of Tor2, GD03, and SZ3, representative strains of SARS-CoV isolated from human 2002–2003, 2003–2004, and palm civet strains, can induce high-titer cross-neutralizing antibodies against pseudotyped SARS-CoV expressing respective S proteins (He et al., 2006c). Di"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T189","span":{"begin":116,"end":124},"obj":"Disease"},{"id":"T190","span":{"begin":263,"end":271},"obj":"Disease"}],"attributes":[{"id":"A189","pred":"mondo_id","subj":"T189","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A190","pred":"mondo_id","subj":"T190","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"llenge (Du et al., 2009b). Particularly, RBDs from the S proteins of Tor2, GD03, and SZ3, representative strains of SARS-CoV isolated from human 2002–2003, 2003–2004, and palm civet strains, can induce high-titer cross-neutralizing antibodies against pseudotyped SARS-CoV expressing respective S proteins (He et al., 2006c). Di"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T460","span":{"begin":139,"end":144},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"llenge (Du et al., 2009b). Particularly, RBDs from the S proteins of Tor2, GD03, and SZ3, representative strains of SARS-CoV isolated from human 2002–2003, 2003–2004, and palm civet strains, can induce high-titer cross-neutralizing antibodies against pseudotyped SARS-CoV expressing respective S proteins (He et al., 2006c). Di"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T200","span":{"begin":57,"end":65},"obj":"Chemical"},{"id":"T201","span":{"begin":296,"end":304},"obj":"Chemical"}],"attributes":[{"id":"A200","pred":"chebi_id","subj":"T200","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A201","pred":"chebi_id","subj":"T201","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"llenge (Du et al., 2009b). Particularly, RBDs from the S proteins of Tor2, GD03, and SZ3, representative strains of SARS-CoV isolated from human 2002–2003, 2003–2004, and palm civet strains, can induce high-titer cross-neutralizing antibodies against pseudotyped SARS-CoV expressing respective S proteins (He et al., 2006c). Di"}

{"project":"LitCovid-sentences","denotations":[{"id":"T205","span":{"begin":27,"end":324},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"llenge (Du et al., 2009b). Particularly, RBDs from the S proteins of Tor2, GD03, and SZ3, representative strains of SARS-CoV isolated from human 2002–2003, 2003–2004, and palm civet strains, can induce high-titer cross-neutralizing antibodies against pseudotyped SARS-CoV expressing respective S proteins (He et al., 2006c). Di"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T589","span":{"begin":69,"end":73},"obj":"PR:000001902"},{"id":"T590","span":{"begin":116,"end":124},"obj":"SP_10"},{"id":"T591","span":{"begin":139,"end":144},"obj":"SP_6;NCBITaxon:9606"},{"id":"T592","span":{"begin":171,"end":181},"obj":"SP_5"},{"id":"T593","span":{"begin":213,"end":231},"obj":"BV_7"},{"id":"T594","span":{"begin":232,"end":242},"obj":"BV_7;GO:0042571"},{"id":"T595","span":{"begin":263,"end":271},"obj":"SP_10"},{"id":"T596","span":{"begin":272,"end":282},"obj":"GO:0010467"},{"id":"T30071","span":{"begin":69,"end":73},"obj":"PR:000001902"},{"id":"T61425","span":{"begin":116,"end":124},"obj":"SP_10"},{"id":"T15708","span":{"begin":139,"end":144},"obj":"SP_6;NCBITaxon:9606"},{"id":"T97182","span":{"begin":171,"end":181},"obj":"SP_5"},{"id":"T7300","span":{"begin":213,"end":231},"obj":"BV_7"},{"id":"T19730","span":{"begin":232,"end":242},"obj":"BV_7;GO:0042571"},{"id":"T30325","span":{"begin":263,"end":271},"obj":"SP_10"},{"id":"T94233","span":{"begin":272,"end":282},"obj":"GO:0010467"}],"text":"llenge (Du et al., 2009b). Particularly, RBDs from the S proteins of Tor2, GD03, and SZ3, representative strains of SARS-CoV isolated from human 2002–2003, 2003–2004, and palm civet strains, can induce high-titer cross-neutralizing antibodies against pseudotyped SARS-CoV expressing respective S proteins (He et al., 2006c). Di"}